Review article: Laryngopharyngeal reflux - The ear, nose and throat patient

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue SUPPL. 1, 2011, Pages 53-57

  Watson, M G ^a  

^a DONCASTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; DOMPERIDONE; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PANTOPRAZOLE; PEPSIN A; PROTON PUMP INHIBITOR; RABEPRAZOLE;

BEHAVIOR MODIFICATION; DIAGNOSTIC PROCEDURE; DIET THERAPY; DRUG DOSE REDUCTION; EAR NOSE THROAT DISEASE; ENT EXAMINATION; ESOPHAGEAL PH MONITORING; HUMAN; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION;

EID: 79952297193     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.4581.x     Document Type: Review

References (18)

1. Koufman JA. The otolaryngologic manifestations of gastro-oesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24hr pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101(Suppl. 53): 1-78.
2. Wiener GJ, Tsukashima R, Kelly C, et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice 2009; 23: 498-504.
3. Ludemann JP, Manoukian J, Shaw K, Bernard C, Davis M, Al-Jubad A. Effects of simulated gastro-oesophageal reflux on the untraumatized rabbit larynx. J.Otolaryngol 1998; 27: 127-31. (Pubitemid 28340585)
4. Groome M, Cotton JP, Borland M, et al. Prevalence of Laryngopharyngeal reflux in a population with gastro-oesophageal reflux. Laryngoscope 2007; 117: 1424-8. (Pubitemid 47356847)
5. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the Reflux Symptom Index (RSI). J Voice 2002; 16: 274-7. (Pubitemid 36626833)
6. Postma GN. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol Suppl 2000; 184: 10-4.
7. Blondeau K, Tack J. Impedance testing is useful in the management of GERD. Am J Gastro 2009; 104: 2664-6.
8. Strugala V, McGlashan JA, Watson MG, Morice AH, Granier B, Dettmar PW. Detection of pepsin using a non-invasive lateral flow test for the diagnosis of extra-oesophageal reflux - results of a pilot study. Gut 2007; 56(Suppl. 111): A212.
9. Sun G, Muddana S, Slaughter JC, et al. A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope 2009; 119: 1639-43.
10. Strugala V, Dettmar PW, Morice AH. Detection of pepsin in sputum and exhaled breath condensate: could be a useful marker for reflux-related respiratory disease? Gastroenterol 2009; 136(5 Suppl. 1): S1895.
11. Talaat M, Gad MS, Magdy EA, et al. Helicobacter pylori infection and chronic, persistent cough: is there an association? J Laryngol Otol 2007; 121: 962-7. (Pubitemid 351650440)
12. McGlashan JA, Johnston LM, Sykes J, Strugala V, Dettmar PW. The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2009; 266: 243-51.
13. Strugala V, Dettmar PW. Alginate in the treatment of extra-esophageal reflux. In: Johnston N, Toohill RJ, eds. Effects, Diagnosis and Management of Extra- Esophageal Reflux. New York: Nova Science Publishers Inc, 2010; 145-168.
14. Karkos PD, Wilson JA. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope 2006; 116: 144-8. (Pubitemid 44383980)
15. Reichel O, Dressel H, Wiederanders K, Issing WJ. Double blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with Laryngopharyngeal reflux. Otolaryngol - Head Neck Surg 2008; 139: 414-20.
16. Gillen D, Wirz AA, Ardill JE, McColl KEL. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterol 1999; 116: 239-47. (Pubitemid 29055344)
17. Boeckxstaens GE, Beamont H, Hatlebakk J, et al. Efficacy and tolerability of the novel reflux inhibitor, AZD3355, as an add-on treatment in GERD patients with symptoms despite proton pump inhibitor therapy. Gastroenterol 2009; 136 (Suppl.): M1875.
18. Keywood CGA, Wakefield M, Tack J. A proof of concept study evaluating the effect of ADX10059, a metatropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-esophageal reflux disease. Gut 2009; 59: 1192-9.